Last reviewed · How we verify

Standard care Hyaluronic acid eye drops

Universidad Nacional de Colombia · Phase 3 active Small molecule

Standard care Hyaluronic acid eye drops is a Ophthalmic lubricant Small molecule drug developed by Universidad Nacional de Colombia. It is currently in Phase 3 development for Treatment of dry eye syndrome.

Hyaluronic acid eye drops work by providing lubrication to the eyes, helping to relieve dryness and irritation.

Hyaluronic acid eye drops work by providing lubrication to the eyes, helping to relieve dryness and irritation. Used for Treatment of dry eye syndrome.

At a glance

Generic nameStandard care Hyaluronic acid eye drops
SponsorUniversidad Nacional de Colombia
Drug classOphthalmic lubricant
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 3

Mechanism of action

This is achieved by creating a protective barrier on the surface of the eye, reducing friction and discomfort. Hyaluronic acid is a naturally occurring substance in the body that helps retain moisture.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Standard care Hyaluronic acid eye drops

What is Standard care Hyaluronic acid eye drops?

Standard care Hyaluronic acid eye drops is a Ophthalmic lubricant drug developed by Universidad Nacional de Colombia, indicated for Treatment of dry eye syndrome.

How does Standard care Hyaluronic acid eye drops work?

Hyaluronic acid eye drops work by providing lubrication to the eyes, helping to relieve dryness and irritation.

What is Standard care Hyaluronic acid eye drops used for?

Standard care Hyaluronic acid eye drops is indicated for Treatment of dry eye syndrome.

Who makes Standard care Hyaluronic acid eye drops?

Standard care Hyaluronic acid eye drops is developed by Universidad Nacional de Colombia (see full Universidad Nacional de Colombia pipeline at /company/universidad-nacional-de-colombia).

What drug class is Standard care Hyaluronic acid eye drops in?

Standard care Hyaluronic acid eye drops belongs to the Ophthalmic lubricant class. See all Ophthalmic lubricant drugs at /class/ophthalmic-lubricant.

What development phase is Standard care Hyaluronic acid eye drops in?

Standard care Hyaluronic acid eye drops is in Phase 3.

What are the side effects of Standard care Hyaluronic acid eye drops?

Common side effects of Standard care Hyaluronic acid eye drops include Eye irritation.

Related